Results 141 to 150 of about 2,680 (197)

Evaluation of sulbactam/durlobactam activity and synergy against highly drug-resistant <i>Acinetobacter baumannii</i> strains. [PDF]

JAC Antimicrob Resist
Halim J, Bouzo J, Carabetta VJ.
europepmc   +1 more source

Eravacycline Treatment for Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Lung Transplant Recipients: A Real-World Retrospective Study. [PDF]

Infect Drug Resist
Chen J, Qian X, Yue B, Lin H, Ding S, Chen J, Huang M.   +6 more
europepmc   +1 more source

Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysis. [PDF]

BMC Infect Dis
Helden SRV, Coyne AJK, Alosaimy S, Molina KC, Kang-Birken SL, Andrade J, King MA, Claeys KC, Hobbs ALV, Perkins Iii NB, Agee J, DeKerlegand A, Biagi M, Veve MP, Tart S, Gore T, Jones BM, Pullinger BM, Schrack MR, Cosimi R, Herbin SR, Judd C, Musawa MA, Rybak MJ.   +23 more
europepmc   +1 more source

Successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> and Enterobacterales coinfection with sulbactam-durlobactam combined with aztreonam: a case report. [PDF]

AME Case Rep
Yang S, Cheng Z, Liu Y, Ni L, Wei C.
europepmc   +1 more source

Integrative review on Acinetobacter baumannii as a multidrug-resistant pathogen: resistance mechanisms and therapeutic perspectives in the context of nosocomial infections. [PDF]

Rev Soc Bras Med Trop
Lima PHM, Lopes CF, Freire JPC, Feliciano LD, Amorim RCO, Mota ML, Cirqueira FF, Lemos FFB, Pedroso SHSP, Melo FF.   +9 more
europepmc   +1 more source

Effective Management of Carbapenem-Resistant Enterobacterales Bloodstream Infection with Organ Dissemination in Prolonged Severe Agranulocytosis Patients with Hematological Malignancy Through Combination Therapies Including Eravacycline. [PDF]

Infect Dis Ther
Lv Y, Zhang X, Cui Q, Li M, Bai L, Yu Y, Li X, Chen X, Wu D, Tang X.   +9 more
europepmc   +1 more source

Eravacycline, the First and Unique Fluorocycline Antibacterial Agent

Journal of Bacteriology and Virology
Mohammad Saydur Rahman, Sharmila Sultana Shathi, G M Al Amin, Fatema Akhter, Md Ferdaus Azam, Sonia Akter, Md Ariful Islam, A K Azad, Young-Sang Koh   +8 more
openaire   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

AMRrounds: susceptibility to the new tetracycline-derivative eravacycline of New Delhi metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i> complex. [PDF]

JAC Antimicrob Resist
Galfo V, Tiseo G, Giordano C, Leonildi A, Lepore A, Pogliaghi M, Riccardi N, Barnini S, Falcone M.   +8 more
europepmc   +1 more source

Emergence of a multidrug-resistant <i>Pseudomonas fulva</i> clinical isolate co-harboring <i>tmexCD3</i>-<i>toprJ3</i>, <i>bla</i> _OXA-1, and <i>bla</i> _IMP-45 on a transferable megaplasmid. [PDF]

Front Cell Infect Microbiol
Wang Z, Li J, Li Y, Chen Z, Ren E, Zhang P.   +5 more
europepmc   +1 more source